Subject: Survey to assess strategies for prevention and management of atherosclerotic cardiovascular disease in patients of dyslipidemia (STOP CVD)
Cardiovascular diseases (CVDs), principally ischemic heart disease and stroke are the leading causes of death worldwide, responsible for 16% and 11%, respectively, of global deaths in 2019. Cardiovascular mortality in low- and middle-income countries (LMICs) remains unacceptably high, being nearly twice that of HICs.
Statins are recommended for ASCVD prevention globally but remain underutilized and underdosed, especially in LMICs. In low-income countries (LICs), only 19.8% of patients receive medicines for secondary prevention of ASCVD, compared to 54.9% in upper- middle-income countries (UMICs). Many patients are undertreated and do not reach current guideline-directed LDL-C targets. Furthermore, up to 30% of patients report statin-related side effects.
Risk factors for ASCVD might be causal or noncausal in the pathogenesis of atherosclerosis, with only the former representing targets for treatment. There is need to better understand which risk factors are causal in atherosclerosis and what are the current practices in prevention and management of ASCVDs.
This multicenter survey is planned is to assess strategies for prevention and management of atherosclerotic cardiovascular disease in patients of dyslipidemia.
We invite you to participate in this survey. On acceptance, you will need to fill the survey questionnaire form provided.
We would encourage you to carefully fill all available information to the fullest in the questionnaire.
If you agree to participate in the said survey, we would request you to sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}
}})